Greg Divis | CEO |
Mike Kanan | CFO |
Geoff Glass | Chairman |
Matt Kaplan | Ladenburg Thalmann |
Francois Brisebois | Laidlaw |
Good morning, ladies and gentlemen, thank you for standing by. And welcome to the Avadel Pharmaceuticals’ Fourth Quarter and Full-Year 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. It is now my pleasure to turn the call over to Mr.